Yewon Jung

Dr. Yewon Jung

orcid

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
16 November 2022 in Journal of Korean Medical Science
Verified
Journal Article
Open access
PDF file
YKYea Eun Kang
Yea Eun Kang
HYHyon-Seung Yi
Hyon-Seung Yi
Min-kyung YeoMin-kyung Yeo
Min-kyung Yeo
JKJung Tae Kim
Jung Tae Kim
DPDanbit Park
Danbit Park
HKHyun Jin Kim
Hyun Jin Kim
Kang YE, et al. J Korean Med Sci. 2022 Nov;37(48):e338. https://doi.org/10.3346/jkms.2022.37.e338

26 January 2025 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
SHSukhwan Hyun
Sukhwan Hyun
JYJigeun Yoo
Jigeun Yoo
YJYewon Jung
Yewon Jung
WSWonkyo Shin
Wonkyo Shin
SSSOO YOUN SONG
SOO YOUN SONG
HYHeon Jong Yoo
Heon Jong Yoo
Background/Objectives: To compare the outcomes of single-port access laparoscopic surgery (SPALS) and single-site robotic surgery (SSRS) for benign gynecological diseases, we retrospectively analyzed clinical data from 367 patients who underwent gynecologic surgery at Sejong Chungnam National University Hospital from October 2020 to December 2023. Methods: Of these 367 patients, 197 underwent SPALS, whereas 170 underwent SSRS. The SPALS group comprised 87 patients who underwent hysterectomy; 107, adnexal surgery (cystectomy: 44, adnexectomy: 63); and 1 myomectomy. The SSRS group included 68 patients who underwent myomectomy; 61, adnexal surgery (cystectomy: 52, adnexectomy: 9); 35, hysterectomy, and 4, sacrocolpopexy. Results: Both surgical techniques were successful, with no patients requiring open surgery. No significant differences were observed in the baseline characteristics between the two groups. Compared with the SPALS group, the SSRS group had a younger age (39.8 ± 9.5 vs. 44.5 ± 12.3 years, p = 0.001). Severe intra-abdominal adhesions were more frequently observed in the SSRS group (p = 0.004). Operation time (118.1 ± 65.9 vs. 57.1 ± 27.3 min, p = 0.001), gas passing time (39.4 ± 15.37 vs. 30.4 ± 13.5 h, p = 0.001), and hospital length of stay (4.26 ± 1.02 vs. 4.02 ± 0.8 days, p = 0.012) were significantly longer in the SSRS group. However, no significant differences were found between the two groups in terms of intraoperative blood loss, intraoperative complications, or readmission rates. Conclusions: SSRS offers a feasible and promising approach for treating gynecological benign diseases. Younger and lower-parity patients tend to undergo SSRS rather than SPALS, with SSRS primarily performed for myomectomy and complex adnexal surgery. However, operation time and gas passing time were significantly longer in the SSRS group.

2 January 2025 in Preprints.org
Verified
Preprint
Open access
PDF file
SHSukhwan Hyun
Sukhwan Hyun
JYJigeun Yoo
Jigeun Yoo
YJYewon Jung
Yewon Jung
WSWonkyo Shin
Wonkyo Shin
SSSOO YOUN SONG
SOO YOUN SONG
HYHeon Jong Yoo
Heon Jong Yoo
Background/Objectives: To compare the outcomes of single-port assessment laparoscopic surgery (SPALS) and single-site robotic surgery (SSRS) for benign gynecological diseases. Methods: The clinical data of 367 patients who underwent gynecologic surgery at Sejong Chungnam National University Hospital from October 2020 to December 2023 were analyzed retrospectively. Of these 367 patients, 197 received SPALS while 170 underwent SSRS. The SPALS group comprise 87 hysterectomies, 107 adnexal surgeries (44 cystectomies, 63 adnexectomies) and 1 myomectomy. The SSRS group includes 68 myomectomies, 61 adnexal surgeries (52 cystectomies, 9 adnexectomies), 35 hysterectomies, and 4 sacrocolpopexies. Results: The results showed that both surgical techniques were successful, and no patients underwent open surgery. There were no significant differences in the baseline characteristics between the two groups. Compared with the SPALS group, the SSRS group had younger age (39.8±9.5 vs 44.5±12.3 years, p = 0.001). Severe intra-abdominal adhesions were more frequently observed in the SSRS group (p = 0.004). Operation time (118.1±65.9 vs 57.1±27.3 min, p = 0.001) and gas passing time (39.4±15.37 vs 30.4±13.5 hours, p = 0.001) were found to be longer, along with more hospital days (4.26±1.02 vs 4.02±0.8 days, p = 0.012), in SSRS group. However, there were no significant differences between the two groups in terms of intraoperative blood loss, intraoperative complications, or readmission rates. Conclusions: SSRS offers a feasible and promising approach for treating gynecological benign diseases. Younger and lower parity patients tend to have SSRS, compare to SPALS, and SSRS was mainly used for myomectomy and complex adnexal surgery. However, operation time and gas passing time were found to be longer in SSRS group.